Posted by Michael Wonder on 29 Sep 2022
TGA provisionally approves Pfizer’s COVID-19 vaccine, Comirnaty (tozinameran) for use in children aged 6 months to less than 5 years
29 September 2022 - On 29 September 2022, the TGA provisionally approved a paediatric dose of Pfizer’s COVID-19 vaccine, Comirnaty (tozinameran), for children aged 6 months to less than 5 years.
As seen with older age groups, it is expected that vaccines for younger children will provide protection from the most severe COVID-19 outcomes, such as hospitalisation and death.
